1.
Rogalski J, Gawlik-Kotelnicka O, Tomczak T. Insights into risk factors of the Metabolic Dysfunction-Associated Steatotic Liver Disease development among patients with schizophrenia. Curr Probl Psychiatry [Internet]. 2024 Nov. 29 [cited 2025 Dec. 15];25:226-38. Available from: https://czasopisma.umlub.pl/cpp/article/view/1266